593 related articles for article (PubMed ID: 21124894)
1. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
Hayashi Y; Chan T; Warashina M; Fukuda M; Ariizumi T; Okabayashi K; Takayama N; Otsu M; Eto K; Furue MK; Michiue T; Ohnuma K; Nakauchi H; Asashima M
PLoS One; 2010 Nov; 5(11):e14099. PubMed ID: 21124894
[TBL] [Abstract][Full Text] [Related]
2. Generation of human induced pluripotent stem (Ips) cells in serum- and feeder-free defined culture and TGF-Β1 regulation of pluripotency.
Yamasaki S; Taguchi Y; Shimamoto A; Mukasa H; Tahara H; Okamoto T
PLoS One; 2014; 9(1):e87151. PubMed ID: 24489856
[TBL] [Abstract][Full Text] [Related]
3. Human iPS cell-derived fibroblast-like cells as feeder layers for iPS cell derivation and expansion.
Du SH; Tay JC; Chen C; Tay FC; Tan WK; Li ZD; Wang S
J Biosci Bioeng; 2015 Aug; 120(2):210-7. PubMed ID: 25622768
[TBL] [Abstract][Full Text] [Related]
4. Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture.
Zou Q; Wu M; Zhong L; Fan Z; Zhang B; Chen Q; Ma F
PLoS One; 2016; 11(2):e0149023. PubMed ID: 26882313
[TBL] [Abstract][Full Text] [Related]
5. Rapid and efficient conversion of integration-free human induced pluripotent stem cells to GMP-grade culture conditions.
Durruthy-Durruthy J; Briggs SF; Awe J; Ramathal CY; Karumbayaram S; Lee PC; Heidmann JD; Clark A; Karakikes I; Loh KM; Wu JC; Hoffman AR; Byrne J; Reijo Pera RA; Sebastiano V
PLoS One; 2014; 9(4):e94231. PubMed ID: 24718618
[TBL] [Abstract][Full Text] [Related]
6. Feeder-free generation and long-term culture of human induced pluripotent stem cells using pericellular matrix of decidua derived mesenchymal cells.
Fukusumi H; Shofuda T; Kanematsu D; Yamamoto A; Suemizu H; Nakamura M; Yamasaki M; Ohgushi M; Sasai Y; Kanemura Y
PLoS One; 2013; 8(1):e55226. PubMed ID: 23383118
[TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cells generated from human adipose-derived stem cells using a non-viral polycistronic plasmid in feeder-free conditions.
Qu X; Liu T; Song K; Li X; Ge D
PLoS One; 2012; 7(10):e48161. PubMed ID: 23110200
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
9. Successful Derivation of an Induced Pluripotent Stem Cell Line from a Genetically Nonpermissive Enhanced Green Fluorescent Protein-Transgenic FVB/N Mouse Strain.
Abbey D; Singh G; Verma I; Derebail S; Kolkundkar U; Chandrashekar DS; Acharya KK; Vemuri MC; Seshagiri PB
Cell Reprogram; 2019 Oct; 21(5):270-284. PubMed ID: 31596624
[TBL] [Abstract][Full Text] [Related]
10. Culture conditions affect cardiac differentiation potential of human pluripotent stem cells.
Ojala M; Rajala K; Pekkanen-Mattila M; Miettinen M; Huhtala H; Aalto-Setälä K
PLoS One; 2012; 7(10):e48659. PubMed ID: 23119085
[TBL] [Abstract][Full Text] [Related]
11. Generation of pig iPS cells: a model for cell therapy.
Montserrat N; Bahima EG; Batlle L; Häfner S; Rodrigues AM; González F; Izpisúa Belmonte JC
J Cardiovasc Transl Res; 2011 Apr; 4(2):121-30. PubMed ID: 21088946
[TBL] [Abstract][Full Text] [Related]
12. Generating induced pluripotent stem cells from common marmoset (Callithrix jacchus) fetal liver cells using defined factors, including Lin28.
Tomioka I; Maeda T; Shimada H; Kawai K; Okada Y; Igarashi H; Oiwa R; Iwasaki T; Aoki M; Kimura T; Shiozawa S; Shinohara H; Suemizu H; Sasaki E; Okano H
Genes Cells; 2010 Sep; 15(9):959-69. PubMed ID: 20670273
[TBL] [Abstract][Full Text] [Related]
13. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
[TBL] [Abstract][Full Text] [Related]
14. Direct reprogramming of fibroblasts into epiblast stem cells.
Han DW; Greber B; Wu G; Tapia N; Araúzo-Bravo MJ; Ko K; Bernemann C; Stehling M; Schöler HR
Nat Cell Biol; 2011 Jan; 13(1):66-71. PubMed ID: 21131959
[TBL] [Abstract][Full Text] [Related]
15. Human-induced pluripotent stem cells produced under xeno-free conditions.
Ross PJ; Suhr ST; Rodriguez RM; Chang EA; Wang K; Siripattarapravat K; Ko T; Cibelli JB
Stem Cells Dev; 2010 Aug; 19(8):1221-9. PubMed ID: 20030562
[TBL] [Abstract][Full Text] [Related]
16. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
[TBL] [Abstract][Full Text] [Related]
18. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts.
Wakao S; Kitada M; Kuroda Y; Shigemoto T; Matsuse D; Akashi H; Tanimura Y; Tsuchiyama K; Kikuchi T; Goda M; Nakahata T; Fujiyoshi Y; Dezawa M
Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9875-80. PubMed ID: 21628574
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.
Rajaei B; Shamsara M; Amirabad LM; Massumi M; Sanati MH
J Cell Physiol; 2017 Oct; 232(10):2616-2625. PubMed ID: 27306424
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming in vivo produces teratomas and iPS cells with totipotency features.
Abad M; Mosteiro L; Pantoja C; Cañamero M; Rayon T; Ors I; Graña O; Megías D; Domínguez O; Martínez D; Manzanares M; Ortega S; Serrano M
Nature; 2013 Oct; 502(7471):340-5. PubMed ID: 24025773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
